Cited by 39Bone health and osteoporosis researchBone Metabolism and DiseasesEpigenetics and DNA Methylation

Epigenetic enzymes influenced by oxidative stress and hypoxia mimetic in osteoblasts are differentially expressed in patients with osteoporosis and osteoarthritis

Open access
Vrtačnik, Peter, Zupan, Janja, Mlakar, Vid, Kranjc, Tilen, Marc, Janja, Kern, Barbara, Ostanek, Barbara·2018·Scientific Reports

Abstract

Epigenetic mechanisms including posttranslational histone modifications and DNA methylation are emerging as important determinants of bone homeostasis. With our case-control study we aimed to identify which chromatin-modifying enzymes could be involved in the pathology of postmenopausal osteoporosis and osteoarthritis while co-regulated by estrogens, oxidative stress and hypoxia. Gene expression of HAT1, KAT5, HDAC6, MBD1 and DNMT3A affected by oxidative stress and hypoxia in an in vitro qPCR screening step performed on an osteoblast cell line was analysed in trabecular bone tissue samples from 96 patients. Their expression was significantly reduced in patients with postmenopausal osteoporosis and osteoarthritis as compared to autopsy controls and significantly correlated with bone mineral density and several bone histomorphometry-derived parameters of bone quality and quantity as well as indicators of oxidative stress, RANK/RANKL/OPG system and angiogenesis. Furthermore, oxidative stress increased DNA methylation levels at the RANKL and OPG promoters while decreasing histone acetylation levels at these two genes. Our study is the first to show that higher expression of HAT1, HDAC6 and MBD1 is associated with superior quantity as well as quality of the bone tissue having a more favourable trabecular structure.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-018-34255-4

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • HAT1 is a cytoplasmic histone deacetylase whose loss is associated with early onset ageing and mitochondrial defects, and whose expression is reduced under treatment with hypoxic agents.

    “HAT1 (FC = −1.12, p = 0.05) is a cytoplasmic histone deacetylase, for which loss is associated with early onset ageing and mitochondrial defects [105], and for which expression is reduced under treatment with hypoxic agents [159].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Vrtačnik, P., Zupan, J., Mlakar, V., Kranjc, T., Marc, J., Kern, B., & Ostanek, B.
Affiliations
University of Ljubljana (SI)
Corresponding author
Ostanek, Barbara
Venue
Scientific Reports
Published
2018-11-01
Volume
8
Issue
1
Pages
16215-16215
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2898532909
Cited by
39
References
33
Citations by year
2026: 1 · 2025: 1 · 2024: 4 · 2023: 7 · 2022: 4 · 2021: 11 · 2020: 7 · 2019: 4
FWCI
5.97
Type
journal article
Language
en
Open access
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Repository of the University of Ljubljana (University of Ljubljana) (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
Javna Agencija za Raziskovalno Dejavnost RS (ARMR19, P3-0298, J3-5511)
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
Keywords
epigenetic enzymes, osteoporosis, osteoarthritis, postmenopausal osteoporosis, osteoblasts, oxidative stress, hypoxia, histone acetylation, histone deacetylase, DNA methylation, HAT1, KAT5, HDAC6, MBD1, DNMT3A, RANKL, OPG, bone mineral density, trabecular bone histomorphometry, angiogenesis, estrogen
MeSH terms
Acetylation, Hypoxia, Bone and Bones, Cell Line, Chromatin, Deferoxamine, Estradiol, Female, Gene Expression Regulation, Histones, Humans, Hydrogen Peroxide, Male, Osteoarthritis, Osteoblasts, Osteoporosis, Oxidative Stress, Epigenesis, Genetic, Epigenomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review